Utility of Thromboelastography to Identify Hypercoagulability in Lung Cancer Related Ischemic Stroke Patients

Lung cancer related hypercoagulability could increase the risk of ischemic stroke. Routine coagulation tests may have limited capacity in evaluating hypercoagulability. The aim of this study was to investigate the ability of thromboelastography (TEG) in the identification of hypercoagulability in pa...

Full description

Bibliographic Details
Main Authors: Xuemei Quan MD, Qixiong Qin MD, Xianting Que MD, Ya Chen MD, Yunfei Wei MD, Hao Chen MD, Qianqian Li MD, Chaoguo Meng MD, Zhijian Liang PhD
Format: Article
Language:English
Published: SAGE Publishing 2020-11-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/1076029620975502
id doaj-0257fff0b5fd47f58cba44fb08e13613
record_format Article
spelling doaj-0257fff0b5fd47f58cba44fb08e136132020-12-02T22:36:18ZengSAGE PublishingClinical and Applied Thrombosis/Hemostasis1938-27232020-11-012610.1177/1076029620975502Utility of Thromboelastography to Identify Hypercoagulability in Lung Cancer Related Ischemic Stroke PatientsXuemei Quan MD0Qixiong Qin MD1Xianting Que MD2Ya Chen MD3Yunfei Wei MD4Hao Chen MD5Qianqian Li MD6Chaoguo Meng MD7Zhijian Liang PhD8 Department of Neurology, , Nanning Guangxi Province, China Department of Neurology, , Nanning Guangxi Province, China Department of Neurology, , Nanning, Guangxi Province, China Department of Neurology, , Nanning Guangxi Province, China Department of Neurology, , Nanning, Guangxi Province, China Department of Neurology, , Nanning Guangxi Province, China Department of Neurology, , Nanning Guangxi Province, China Department of Neurology, , Nanning Guangxi Province, China Department of Neurology, , Nanning Guangxi Province, ChinaLung cancer related hypercoagulability could increase the risk of ischemic stroke. Routine coagulation tests may have limited capacity in evaluating hypercoagulability. The aim of this study was to investigate the ability of thromboelastography (TEG) in the identification of hypercoagulability in patients with lung cancer and cryptogenic ischemic stroke (LCIS). Between January 2016 and December 2018, whole citrated blood from LCIS patients (n = 35) and age- and gender-matched lung cancer patients and healthy volunteers were used for TEG and routine coagulation tests. The coagulation indicator and clinical data were compared among the 3 groups. There were 27/35 (77.14%) on TEG and 18/35 (51.43%) on routine coagulation tests of LCIS patients who had evidence of hypercoagulability. The detection rate of hypercoagulability by TEG in LCIS patients was higher than routine coagulation tests ( P = 0.018). Comparing with lung cancer patients and healthy controls, LCIS patients have a significantly higher maximum amplitude (MA), fibrinogen, and D-dimer. Multivariate analysis showed that D-dimer and MA were significantly associated with ischemic stroke in lung cancer patients. ROC curve showed that the area under the curve of TEG (0.790 ± 0.048, 95% CI: 0.697-0.864) was significantly higher than routine coagulation tests (0.673 ± 0.059, 95% CI: 0.572-0.763) ( P = 0.04) in identifying hypercoagulability in LCIS patients. Therefore, TEG could identify hypercoagulability in LCIS patients and healthy controls. Identification of hypercoagulability in lung cancer patients by TEG may be helpful to prevent the occurrence of LCIS.https://doi.org/10.1177/1076029620975502
collection DOAJ
language English
format Article
sources DOAJ
author Xuemei Quan MD
Qixiong Qin MD
Xianting Que MD
Ya Chen MD
Yunfei Wei MD
Hao Chen MD
Qianqian Li MD
Chaoguo Meng MD
Zhijian Liang PhD
spellingShingle Xuemei Quan MD
Qixiong Qin MD
Xianting Que MD
Ya Chen MD
Yunfei Wei MD
Hao Chen MD
Qianqian Li MD
Chaoguo Meng MD
Zhijian Liang PhD
Utility of Thromboelastography to Identify Hypercoagulability in Lung Cancer Related Ischemic Stroke Patients
Clinical and Applied Thrombosis/Hemostasis
author_facet Xuemei Quan MD
Qixiong Qin MD
Xianting Que MD
Ya Chen MD
Yunfei Wei MD
Hao Chen MD
Qianqian Li MD
Chaoguo Meng MD
Zhijian Liang PhD
author_sort Xuemei Quan MD
title Utility of Thromboelastography to Identify Hypercoagulability in Lung Cancer Related Ischemic Stroke Patients
title_short Utility of Thromboelastography to Identify Hypercoagulability in Lung Cancer Related Ischemic Stroke Patients
title_full Utility of Thromboelastography to Identify Hypercoagulability in Lung Cancer Related Ischemic Stroke Patients
title_fullStr Utility of Thromboelastography to Identify Hypercoagulability in Lung Cancer Related Ischemic Stroke Patients
title_full_unstemmed Utility of Thromboelastography to Identify Hypercoagulability in Lung Cancer Related Ischemic Stroke Patients
title_sort utility of thromboelastography to identify hypercoagulability in lung cancer related ischemic stroke patients
publisher SAGE Publishing
series Clinical and Applied Thrombosis/Hemostasis
issn 1938-2723
publishDate 2020-11-01
description Lung cancer related hypercoagulability could increase the risk of ischemic stroke. Routine coagulation tests may have limited capacity in evaluating hypercoagulability. The aim of this study was to investigate the ability of thromboelastography (TEG) in the identification of hypercoagulability in patients with lung cancer and cryptogenic ischemic stroke (LCIS). Between January 2016 and December 2018, whole citrated blood from LCIS patients (n = 35) and age- and gender-matched lung cancer patients and healthy volunteers were used for TEG and routine coagulation tests. The coagulation indicator and clinical data were compared among the 3 groups. There were 27/35 (77.14%) on TEG and 18/35 (51.43%) on routine coagulation tests of LCIS patients who had evidence of hypercoagulability. The detection rate of hypercoagulability by TEG in LCIS patients was higher than routine coagulation tests ( P = 0.018). Comparing with lung cancer patients and healthy controls, LCIS patients have a significantly higher maximum amplitude (MA), fibrinogen, and D-dimer. Multivariate analysis showed that D-dimer and MA were significantly associated with ischemic stroke in lung cancer patients. ROC curve showed that the area under the curve of TEG (0.790 ± 0.048, 95% CI: 0.697-0.864) was significantly higher than routine coagulation tests (0.673 ± 0.059, 95% CI: 0.572-0.763) ( P = 0.04) in identifying hypercoagulability in LCIS patients. Therefore, TEG could identify hypercoagulability in LCIS patients and healthy controls. Identification of hypercoagulability in lung cancer patients by TEG may be helpful to prevent the occurrence of LCIS.
url https://doi.org/10.1177/1076029620975502
work_keys_str_mv AT xuemeiquanmd utilityofthromboelastographytoidentifyhypercoagulabilityinlungcancerrelatedischemicstrokepatients
AT qixiongqinmd utilityofthromboelastographytoidentifyhypercoagulabilityinlungcancerrelatedischemicstrokepatients
AT xiantingquemd utilityofthromboelastographytoidentifyhypercoagulabilityinlungcancerrelatedischemicstrokepatients
AT yachenmd utilityofthromboelastographytoidentifyhypercoagulabilityinlungcancerrelatedischemicstrokepatients
AT yunfeiweimd utilityofthromboelastographytoidentifyhypercoagulabilityinlungcancerrelatedischemicstrokepatients
AT haochenmd utilityofthromboelastographytoidentifyhypercoagulabilityinlungcancerrelatedischemicstrokepatients
AT qianqianlimd utilityofthromboelastographytoidentifyhypercoagulabilityinlungcancerrelatedischemicstrokepatients
AT chaoguomengmd utilityofthromboelastographytoidentifyhypercoagulabilityinlungcancerrelatedischemicstrokepatients
AT zhijianliangphd utilityofthromboelastographytoidentifyhypercoagulabilityinlungcancerrelatedischemicstrokepatients
_version_ 1724401807364456448